trial · primary record
Dexketoprofen / Butylscopolamine in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.)
Primary Dysmenorrhea
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 130 |
| Primary completion | 2026-05-07 |
| Primary endpoint | To evaluate the efficacy of the fixed-dose combination of dexketoprofen/butylscopolamine compared with dexketoprofen monotherapy in reducing pain intensity associated with primary dysmenorrhea. |
| Registry ID | NCT07901894 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:45.768Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07901894
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.